Scotland approves new treatment option for multiple myeloma patients - PharmaTimes Blenrep combination offers improved survival for those ineligible for lenalidomide

#Haematology #Oncology #Scotland #NHSScotland #multiplemyeloma #GSK #Blenrep #belantamabmafodotin #Blenrepcombination #lenalidomide #ScottishMedicinesConsortium #SMC #bortezomibanddexamethasone #BVd #SMCrecommendation #phase3data #DREAMM7study #progressionfreesurvival
zurl.co/ydmDa

Scotland approves zanubrutinib for relapsed mantle cell lymphoma - PharmaTimes New treatment option now available across all UK nations

#NHSScotland #ScottishMedicinesConsortium #Haematology #BeOneMedicinesUK #BeOne #SMC #SMCrecommendation #zanubrutinib #BRUKINSA #relapsedmantlecelllymphoma #MCL #MCLpatients #refractorymantlecelllymphoma #nonHodgkinlymphoma #LymphomaAction #BeatsonWestofScotlandCancerCentre
zurl.co/lk0uJ